SciVision Biotech Inc. (TPE:1786)
Taiwan · Delayed Price · Currency is TWD 49.55
0.00 (0.00%)
Aug 19, 2026, 1:30 PM CST
SciVision Biotech Market Cap
SciVision Biotech has a market cap or net worth of 3.71 billion as of August 19, 2026. Its market cap has decreased by -42.93% in one year.
Market Cap
3.71B
Enterprise Value
3.47B
Revenue
889.15M
Ranking
n/a
PE Ratio
20.86
Stock Price
49.55
ChartMarket Cap Chart
Since December 29, 2010, SciVision Biotech's market cap has increased from 1.23B to 3.71B, an increase of 201.81%. That is a compound annual growth rate of 7.31%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 19, 2026 | 3.71B | -29.26% |
| Dec 31, 2025 | 5.24B | -29.80% |
| Dec 31, 2024 | 7.47B | 42.10% |
| Dec 29, 2023 | 5.25B | 46.46% |
| Dec 30, 2022 | 3.59B | 9.27% |
| Dec 30, 2021 | 3.28B | -12.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Medeon Biodesign | 6.00B |
| Pacific Hospital Supply | 5.62B |
| Formosa Optical Technology | 5.40B |
| St.Shine Optical | 4.76B |
| Bionime | 4.42B |
| Maxigen Biotech | 3.59B |
| ICARES Medicus | 3.47B |
| Nang Kuang Pharmaceutical | 3.21B |